207 related articles for article (PubMed ID: 7609053)
1. The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.
Clark NM; Hannibal MC; Markovitz DM
J Virol; 1995 Aug; 69(8):4854-62. PubMed ID: 7609053
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation.
Hilfinger JM; Clark N; Smith M; Robinson K; Markovitz DM
J Virol; 1993 Jul; 67(7):4448-53. PubMed ID: 8510231
[TBL] [Abstract][Full Text] [Related]
3. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements.
Markovitz DM; Smith MJ; Hilfinger J; Hannibal MC; Petryniak B; Nabel GJ
J Virol; 1992 Sep; 66(9):5479-84. PubMed ID: 1501284
[TBL] [Abstract][Full Text] [Related]
4. Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer.
Fu GK; Markovitz DM
J Biol Chem; 1996 Aug; 271(32):19599-605. PubMed ID: 8702655
[TBL] [Abstract][Full Text] [Related]
5. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
6. Multiple cis-acting elements in the human immunodeficiency virus type 2 enhancer mediate the response to T-cell receptor stimulation by antigen in a T-cell hybridoma line.
Hannibal MC; Markovitz DM; Nabel GJ
Blood; 1994 Apr; 83(7):1839-46. PubMed ID: 8142652
[TBL] [Abstract][Full Text] [Related]
7. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells.
Leiden JM; Wang CY; Petryniak B; Markovitz DM; Nabel GJ; Thompson CB
J Virol; 1992 Oct; 66(10):5890-7. PubMed ID: 1527846
[TBL] [Abstract][Full Text] [Related]
8. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
Tong-Starksen SE; Welsh TM; Peterlin BM
J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
Chan YJ; Chiou CJ; Huang Q; Hayward GS
J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
[TBL] [Abstract][Full Text] [Related]
10. Phorbol ester reduces constitutive nuclear NF kappa B and inhibits HIV-1 production in mature human monocytic cells.
Mufson RA; Myers C; Turpin JA; Meltzer M
J Leukoc Biol; 1992 Dec; 52(6):637-44. PubMed ID: 1464736
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes.
Arenzana-Seisdedos F; Fernandez B; Dominguez I; Jacqué JM; Thomas D; Diaz-Meco MT; Moscat J; Virelizier JL
J Virol; 1993 Nov; 67(11):6596-604. PubMed ID: 8411362
[TBL] [Abstract][Full Text] [Related]
12. Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer.
Hiscott J; Alper D; Cohen L; Leblanc JF; Sportza L; Wong A; Xanthoudakis S
J Virol; 1989 Jun; 63(6):2557-66. PubMed ID: 2542571
[TBL] [Abstract][Full Text] [Related]
13. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.
Jacqué JM; Fernández B; Arenzana-Seisdedos F; Thomas D; Baleux F; Virelizier JL; Bachelerie F
J Virol; 1996 May; 70(5):2930-8. PubMed ID: 8627768
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
Maciaszek JW; Talmage DA; Viglianti GA
J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
[TBL] [Abstract][Full Text] [Related]
15. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ
EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080
[TBL] [Abstract][Full Text] [Related]
16. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation.
Sambucetti LC; Cherrington JM; Wilkinson GW; Mocarski ES
EMBO J; 1989 Dec; 8(13):4251-8. PubMed ID: 2556267
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
Twu JS; Chu K; Robinson WS
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression.
Pomerantz RJ; Feinberg MB; Trono D; Baltimore D
J Exp Med; 1990 Jul; 172(1):253-61. PubMed ID: 2193097
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.
Hazan U; Thomas D; Alcami J; Bachelerie F; Israel N; Yssel H; Virelizier JL; Arenzana-Seisdedos F
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7861-5. PubMed ID: 2146676
[TBL] [Abstract][Full Text] [Related]
20. Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells.
Roulston A; Beauparlant P; Rice N; Hiscott J
J Virol; 1993 Sep; 67(9):5235-46. PubMed ID: 8394446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
